Published in
Elsevier, Neuromuscular Disorders, 1(28), p. 4-15, 2018
DOI: 10.1016/j.nmd.2017.10.004
Links
Tools
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophy
Journal article published in 2018 by
Nathalie Goemans,
Eugenio Mercuri,
Elena Belousova,
Hirofumi Komaki,
Alberto Dubrovsky,
Craig M. McDonald 
,
John E. Kraus,
Afrodite Lourbakos,
Zhengning Lin,
Giles Campion,
Susanne X. Wang,
Craig Campbell,
A. Araujo,
E. Bertini,
P. Born
and other authors.
,
John E. Kraus,
Afrodite Lourbakos,
Zhengning Lin,
Giles Campion,
Susanne X. Wang,
Craig Campbell,
A. Araujo,
E. Bertini,
P. Born
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 